Type to search

World’s First Clinical Trial to Test New Drug Glenzocimab for Heart Attacks | PTF
Acticor Biotech Announces the Enrollment of the First US Patient in Its Phase 2/3 Study ACTISAVE for the Treatment of Stroke | Pharmtech Focus
Acticor Biotech Obtains "PRIME" Status From the European Medicines Agency for Glenzocimab in the Treatment of Stroke | Pharmtech Focus